(Q43754689)

26 November 2017

Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction (English)

1 reference

26 November 2017

myocardial infarction

1 reference

Ishihara M

1

1 reference

26 November 2017

Inoue I

2

1 reference

26 November 2017

Kawagoe T

3

1 reference

26 November 2017

Shimatani Y

4

1 reference

26 November 2017

Kurisu S

5

1 reference

26 November 2017

Nishioka K

6

1 reference

26 November 2017

Kouno Y

7

1 reference

26 November 2017

Umemura T

8

1 reference

26 November 2017

Nakamura S

9

1 reference

26 November 2017

Sato H

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

1 reference

26 November 2017

38

1 reference

26 November 2017

4

1 reference

26 November 2017

1007-1011

1 reference

Diabetes and cardiovascular disease. The Framingham study

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Prodromal angina limits infarct size. A role for ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of "preconditioning"

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Preconditioning the human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Acute hyperglycemia abolishes ischemic preconditioning in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901477-2

7 January 2021

10.1016/S0735-1097(01)01477-2

Identifiers

DOI

1 reference

26 November 2017

1 reference